FDA gives emergency approval to rapid, cheap coronavirus antigen test By Yasemin Saplakoglu Abbott Lab's rapid antigen test can be run without lab equipment in 15 minutes.
Health experts frustrated with new CDC coronavirus testing guidelines By Yasemin Saplakoglu In an abrupt switch, the CDC changed its COVID-19 testing guidance.
China started giving experimental COVID-19 vaccine to medical workers in July By Rachael Rettner The vaccine has been approved for emergency use in medical workers, customs and border officials and other high risk groups.
FDA allows wide use of plasma for COVID-19 with little data that it works By Nicoletta Lanese Last week, the FDA stated it needed much more data to authorize the treatment.
First case of coronavirus reinfection confirmed, researchers say By Yasemin Saplakoglu A man in Hong Kong was reinfected with the novel coronavirus twice, but didn't develop any symptoms the second time.
Coronavirus news of the week (VIDEO) By Nicoletta Lanese Catch up on important COVID-19 news from Live Science.
Fishing boat outbreak suggests antibodies protect against COVID-19 reinfection By Rachael Rettner Three crew members had neutralizing antibodies against the virus prior to the boat's departure.
COVID-19 has the potential to be as deadly as the 1918 flu By Yasemin Saplakoglu Mortality rates in New York City during the early COVID-19 outbreak and in the peak of the 1918 flu pandemic were "in the same ballpark."
FDA wants more proof COVID-19 plasma therapy works By Nicoletta Lanese The agency is waiting on more data from "gold standard" clinical trials.
What if a powerful hurricane hits during the pandemic? Here's how to prevent a double disaster. By Nicoletta Lanese A new model hints that sending evacuees to counties with low COVID-19 spread may help minimize cases.
FDA approves new saliva test for COVID-19 that's simple, cheap and available now By Rachael Rettner The test doesn't require any proprietary equipment or technology, meaning designated laboratories could follow a specific protocol to conduct their own tests.
Novavax COVID-19 vaccine enters second round of human trials By Nicoletta Lanese The trial will include 2,665 healthy adults and 240 medically stable adults with HIV.
Depression and anxiety are skyrocketing in young adults amid pandemic By Rachael Rettner The new findings "highlight the broad impact of the pandemic and the need to prevent and treat these conditions," the authors wrote.
Live Science podcast 'Life's Little Mysteries' special report: Coronavirus (Aug. 13) By Live Science Staff In this special episode of Life's Little Mysteries, we'll give you the latest news and answer frequently asked questions about the new coronavirus and COVID-19.
Should you ditch your gaiter as a face mask? Not so fast, scientists say. By Yasemin Saplakoglu Some masks are more protective than others. But a new study didn't show which ones work best.
That COVID-19 vaccine Russia approved? It's only cleared for use in a small group of people. By Nicoletta Lanese The vaccine cannot be fully approved until 2021, according to its registration certificate.
Don't wear masks with valves, CDC says By Rachael Rettner Masks with these one-way valves expel respiratory droplets from the wearer into the air.
Vaping linked with much higher risk of getting COVID-19 By Rachael Rettner The study involved more than 4,300 U.S. teens and young adults.
Could cat drugs treat humans with COVID-19? By Nicoletta Lanese Two experimental drugs for feline coronavirus could show promise against COVID-19.
Russia approves 'Sputnik V' COVID-19 vaccine with little human testing By Nicoletta Lanese Only late-stage human trials can show that a vaccine is both safe and effective.
